ChemTree and HelixTree are ported to IBM's AIX 5L OS

Contact: Rudy Parker, Senior Account Manager - 406.585.8137 ext. 204. Click here to send an email.

Bozeman, MT (January 2, 2003) - Golden Helix, Inc. announced today it has successfully ported their HelixTree genetics analysis software and ChemTree sequential screening software to IBM's powerful AIX 5L platform. AIX 5L, an IBM UNIX OS, is designed for complex algorithms and resource intensive applications. It is also the native platform for IBM, which is used by many pharmaceutical companies for “database searching, chemical property computation, sophisticated quantum mechanical computations and clustering”.

AIX 5L is supported by much of the software available through IBM Life Sciences Division. The addition of HelixTree and ChemTree to those products already available to AIX 5L will give users more control and capability in the drug discovery process and save pharmaceutical companies, much on time and resources.

"Golden Helix is dedicated to meeting all the intense data analysis needs of the life sciences industry," remarked Christophe Lambert, CEO of Golden Helix, Inc. "With IBM, a longtime leader in the software industry, moving into the bioinformatics industry, it is very beneficial to both companies to have our software interoperate."

ChemTree® and HelixTree® are also available for Windows 2000, Windows NT, Linux, and many other UNIX operating systems.

About Golden Helix, Inc.

Founded in 1998 in Bozeman, MT, Golden Helix is a leading provider of data analysis software products and services designed to accelerate life science research and increase pharmaceutical R&D productivity. The company's products enable hundreds of researchers at the world's top pharmaceutical, biotech and non-profit research organizations to discover the genes that cause disease, improve target and lead discovery processes, and advance pharmacogenetic initiatives. Its products have been cited in nearly 100 peer reviewed publications that detail ground-breaking research for discovering the genetic and environmental basis of disease and creating safer and more effective medicines.
Golden Helix is committed to Accelerating the Quest for Significance.
For more information, please visit www.goldenhelix.com.